RP Bio Inc. (KOSDAQ:314140)
6,290.00
-130.00 (-2.02%)
At close: Jan 22, 2026
RP Bio Revenue
RP Bio had revenue of 33.22B KRW in the quarter ending September 30, 2025, with 18.21% growth. This brings the company's revenue in the last twelve months to 134.21B, up 4.65% year-over-year. In the year 2024, RP Bio had annual revenue of 123.97B, down -17.93%.
Revenue (ttm)
134.21B
Revenue Growth
+4.65%
P/S Ratio
0.42
Revenue / Employee
n/a
Employees
n/a
Market Cap
55.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 123.97B | -27.08B | -17.93% |
| Dec 31, 2023 | 151.05B | 12.94B | 9.37% |
| Dec 31, 2022 | 138.11B | 23.15B | 20.13% |
| Dec 31, 2021 | 114.96B | 17.04B | 17.40% |
| Dec 31, 2020 | 97.92B | 28.07B | 40.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmax Nbt | 293.75B |
| Korea Arlico Pharm | 205.21B |
| Jin Yang Pharmaceutical | 117.19B |
| GeneBioTech Co. ,Ltd | 92.28B |
| Sinil Pharmaceutical | 80.97B |
| Korean Drug | 62.21B |
| Kyung Nam Pharm | 56.18B |
| Eagle Veterinary Technology Co.,Ltd | 42.51B |